Alnylam Pharmaceuticals, Inc. (ALNY)
ALNY price $225.10 -5.61 -2.43%
- Ticker
- ALNY
- Price
- $225.10
- Change
- -5.61 -2.43%
- Market cap
- $30.12B
- P/E
- 37.82
- Forward P/E
- 33.86
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 70
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company primarily dedicated to the discovery, development, and commercialization of innovative therapeutic solutions leveraging ribonucleic acid interference (RNAi) technology. Its robust pipeline of RNAi-based treatments addresses a range of critical therapeutic areas, including inherited genetic disorders, cardio-metabolic conditions, hepatic infectious…